-
Study aim
-
Determining the effect of Malva sylvestris mouthwash on chemotherapy-induced stomatitis in cancer patients
-
Design
-
A clinical trial with a control group, with parallel groups, double-blind, randomized, on 70 patients
-
Settings and conduct
-
The research population is cancer patients in Rafsanjan city. The samples are selected according to the available method and based on the selection criteria and by the random minimization method based on the severity of stomatitis and the amount of pain in two intervention and control groups. Patients in the intervention group received Khatami mouthwash and the control group received chlorhexidine mouthwash for fourteen days.
-
Participants/Inclusion and exclusion criteria
-
Full consciousness, consent to participate in the study, confirmation of cancer, chemotherapy without simultaneous radiation therapy, having stomatitis caused by first to third degree chemotherapy, at least one history of chemotherapy, age between 20 and 75 years, no history of sensitivity According to the malvaceae family, not having a mucosal lesion in the oral cavity before chemotherapy treatment, not being pregnant and not breastfeeding are the criteria for entering the study. Irregular use of mouthwash in terms of time and amount (forgetting 3 alternate days in a 14-day period completely), use of another mouthwash during the study, fever above 5.38, patient's decision to leave the study and unwillingness to use mouthwash and the outcome Any conditions that cause not to use mouthwash, such as worsening of the patient's condition, death, constitute the exclusion criteria.
-
Intervention groups
-
Patients keep fifteen milliliters of mouthwash solution in their mouth for three minutes for fourteen days and spit it out. The intervention group uses marshmallow mouthwash. The control group receives normal chlorhexidine mouthwash solution.
-
Main outcome variables
-
Stomatitis; pain caused by stomatitis